1. Home
  2. FRSX vs GOVX Comparison

FRSX vs GOVX Comparison

Compare FRSX & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

HOLD

Current Price

$2.15

Market Cap

4.0M

Sector

Technology

ML Signal

HOLD

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$1.39

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRSX
GOVX
Founded
N/A
2001
Country
Israel
United States
Employees
N/A
17
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
4.0M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
FRSX
GOVX
Price
$2.15
$1.39
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$200.00
AVG Volume (30 Days)
65.5K
64.3K
Earning Date
03-24-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.12
52 Week High
$3.00
$4.40

Technical Indicators

Market Signals
Indicator
FRSX
GOVX
Relative Strength Index (RSI) 51.53 35.14
Support Level $2.05 $0.55
Resistance Level $2.33 $4.40
Average True Range (ATR) 0.21 0.17
MACD -0.08 -0.03
Stochastic Oscillator 9.47 12.54

Price Performance

Historical Comparison
FRSX
GOVX

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: